eVox Brain Map for Pain

Did you know? 100 million people in the United States are affected by chronic pain1. That’s over 30% of the population!

Pain exists in our bodies for a reason. It tells us to stop grabbing that sharp object or to stop walking on hot pavement. But chronic pain, defined as pain that lasts longer than 6 months, is a different story.

Chronic pain is more than a symptom. It is a debilitating issue that changes the brain’s structure, chemistry, and activity. For many people, even the strongest drugs can fail to damper discomfort. The search for better pain management options has led many doctors to use biofeedback as a successful treatment option2.

Biofeedback has been shown to decrease headache3 and migraine intensity4, reduce chronic muscle pain2, and alleviate pain associated with fibromyalgia5.

Under the guidance of your doctor, the biofeedback feature of the eVox System can help you learn how to turn your brain’s pain signals down. Take a step toward pain-free living and talk to your doctor about the eVox Brain Map.

Since following my doctor’s recommendations and completing biofeedback training, I am finally feeling like myself again.
– Dean J., Spokane, WA

1 Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: Relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press, 2011.
2 Sielski R, Rief W, Glombiewski JA (2016). Efficacy of Biofeedback in Chronic back pain: A meta-analysis. Int J Behav Med. Jun 15.
3 Nestoriuc Y, et al (2008). Biofeedback Treatment for Headache Disorders: A Comprehensive Efficacy Review Applied Psychophysiology and Biofeedback, 33 (3), 125-14
4 Nestoriuc Y, Martin A (2007). Efficacy of biofeedback for migraine: A meta-analysis Pain, 128 (1), 111-127
5 Holtorf, K. (2008). Diagnosis and Treatment of Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysfunction in Patients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). Journal of Chronic Fatigue Syndrome, 14(3), 59-88.